Streetbeat News

Analyst Ratings

LUV

Raymond James analyst Savanthi Syth maintains a Strong Buy rating on Southwest Airlines (NYSE:LUV) and raises the price target from $45 to $47.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:16 am

ALK

Raymond James analyst Savanthi Syth maintains a Strong Buy rating on Alaska Air Gr (NYSE:ALK) and raises the price target from $70 to $75.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:15 am

MRCY

Raymond James analyst Brian Gesuale maintains an Outperform rating on Mercury Systems (NASDAQ:MRCY) but lowers the price target from $55 to $40.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:08 am

BMEA

EF Hutton analyst Michael King reiterated a Buy rating on Biomea Fusion (NASDAQ:BMEA) and maintained a $32 price target.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:08 am

STOK

Needham analyst Joseph Stringer reiterated a Buy rating on Stoke Therapeutics (NASDAQ:STOK) and maintained a $25 price target.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:07 am

UBX

Wedbush analyst Andreas Argyrides downgraded Unity Biotechnology (NASDAQ:UBX) from Outperform to Neutral and lowered the price target from $3 to $2.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:05 am

ESTC

William Blair analyst Kamil Mielczarek has reinstated Elastic (NYSE:ESTC) with a Market Perform rating.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 10:53 am

ALLO

Oppenheimer analyst Mark Breidenbach assumes Allogene Therapeutics (NASDAQ:ALLO) with an Outperform rating and announces a price target of $28.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 10:52 am

ALPN

Oppenheimer analyst Mark Breidenbach assumes Alpine Immune Sciences (NASDAQ:ALPN) with an Outperform rating and announces a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 10:51 am

CUE

Oppenheimer analyst Mark Breidenbach assumes Cue Biopharma (NASDAQ:CUE) with an Outperform rating and announces a price target of $10.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 10:50 am